CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- 4 Shares withheld for taxes PRESIDENT AND CFO gave up 5,080 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF EXECUTIVE OFFICER gave up 10,840 shares (to pay taxes)
- 4 Grant or award SVP, FINANCE acquired 2,810 shares (grant or award)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Shareholder vote results
- 4 Grant or award Director acquired 1,148 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- 4 Grant or award Director acquired 3,041 shares (grant or award)
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 10-Q Report Quarterly Report
Page 8 of 39 · 770 filings